The recent outbreak of the Zika virus has lit a fire under government agencies and the diagnostic industry to develop tests to battle the spread of the virus. Taking a big step in that direction, the FDA authorized emergency use of a molecular test developed by a Quest Diagnostics subsidiary that the company plans to make broadly accessible to U.S. doctors, including Puerto Rico. Read More
